Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic Indications
Abstract
Share and Cite
Kupryś-Lipińska, I.; Kuna, P. Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic Indications. Adv. Respir. Med. 2009, 77, 43-51. https://doi.org/10.5603/ARM.27844
Kupryś-Lipińska I, Kuna P. Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic Indications. Advances in Respiratory Medicine. 2009; 77(1):43-51. https://doi.org/10.5603/ARM.27844
Chicago/Turabian StyleKupryś-Lipińska, Izabela, and Piotr Kuna. 2009. "Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic Indications" Advances in Respiratory Medicine 77, no. 1: 43-51. https://doi.org/10.5603/ARM.27844